Blue Water Biotech, Inc. /
WraSer, LLC and Xspire Pharma, LLC
Blue Water Biotech to buy WraSer pharmaceutical assets
- Terms
- Not stated
- Stage
- Agreement signed




What happened
Blue Water Biotech, Inc. entered into an asset purchase agreement with WraSer, LLC and Xspire Pharma, LLC for six FDA-approved pharmaceutical assets across several indications, including cardiology, otic infections and pain management.
The stated consideration includes cash payments, 1.0 million shares of common stock and an additional cash payment one year after the closing date.
The source
Everything on this page comes from the source below.
Blue Water Biotech to buy WraSer pharmaceutical assets
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly